Ingo Schmidt‐Wolf
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 37
- Cancer Treatment and Pharmacology 9
- Neutropenia and Cancer Infections 7
- Hematology 20
- Multiple Myeloma Research and Treatments 16
- Co-authors
- Axel Glasmacher (13 shared papers)E. Kettner (1 shared paper)Karsten Ridwelski (1 shared paper)Marco Niedergethmann (1 shared paper)Christof Burkart (1 shared paper)Helmut Oettle (1 shared paper)Stefan Post (1 shared paper)Bernd Doerken (1 shared paper)
- Journals
- Blood (9 papers)International Journal of Molecular Sciences (4 papers)Journal of Clinical Oncology (3 papers)British Journal of Haematology (2 papers)Cellular Immunology (2 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Ingo Schmidt‐Wolf
70 papers receiving 3.5k citations
Ingo Schmidt‐Wolf's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 2.7k
- Cancer Research 557
- Hematology 380
- Family Practice 71
- Epidemiology 1.1k
Countries citing papers authored by Ingo Schmidt‐Wolf
This map shows the geographic impact of Ingo Schmidt‐Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Schmidt‐Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Schmidt‐Wolf more than expected).
Fields of papers citing papers by Ingo Schmidt‐Wolf
This network shows the impact of papers produced by Ingo Schmidt‐Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Schmidt‐Wolf. The network helps show where Ingo Schmidt‐Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingo Schmidt‐Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer Hit paper breakdown → | 2007 | 1754 |
| 2 | 2003 | 191 | |
| 3 | 1999 | 180 | |
| 4 | 2006 | 176 | |
| 5 | 2003 | 136 | |
| 6 | 2000 | 117 | |
| 7 | 2004 | 116 | |
| 8 | 2010 | 108 | |
| 9 | 2006 | 76 | |
| 10 | 1999 | 72 | |
| 11 | 2006 | 65 | |
| 12 | 1998 | 61 | |
| 13 | 2006 | 54 | |
| 14 | 2003 | 49 | |
| 15 | 2007 | 40 | |
| 16 | 2013 | 29 | |
| 17 | 2003 | 23 | |
| 18 | 2015 | 23 | |
| 19 | 2017 | 22 | |
| 20 | 2006 | 19 |
About Ingo Schmidt‐Wolf
Ingo Schmidt‐Wolf is a scholar working on Oncology, Hematology, Molecular Biology, Immunology and Epidemiology, having authored 73 papers that have together received 3.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (16 papers), Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (9 papers), Cancer Treatment and Pharmacology (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Neutropenia and Cancer Infections (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (557 citations), Hematology (380 citations), Family Practice (71 citations) and Epidemiology (1.1k citations). Ingo Schmidt‐Wolf has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Axel Glasmacher, E. Kettner, Karsten Ridwelski, Marco Niedergethmann, Christof Burkart, Helmut Oettle, Stefan Post, Bernd Doerken, P. Neuhaus and H Schramm. Their work appears in journals such as Blood, International Journal of Molecular Sciences, Journal of Clinical Oncology, British Journal of Haematology and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.